tiprankstipranks
Trending News
More News >
Krystal Biotech (KRYS)
NASDAQ:KRYS
US Market

Krystal Biotech (KRYS) Ratios

Compare
602 Followers

Krystal Biotech Ratios

KRYS's free cash flow for Q3 2025 was $0.00. For the 2025 fiscal year, KRYS's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
10.14 17.76 13.30 17.18 17.80
Quick Ratio
9.73 17.55 13.30 17.18 17.80
Cash Ratio
4.30 10.83 5.61 13.26 17.36
Solvency Ratio
1.99 0.40 -3.75 -2.04 -1.62
Operating Cash Flow Ratio
1.93 -2.68 -3.49 -1.86 -1.69
Short-Term Operating Cash Flow Coverage
103.77 0.00 -64.43 0.00 -3.17
Net Current Asset Value
$ 823.43M$ 548.20M$ 347.56M$ 409.55M$ 256.30M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 0.02 0.01 0.04
Debt-to-Equity Ratio
<0.01 0.01 0.02 0.01 0.04
Debt-to-Capital Ratio
<0.01 0.01 0.02 0.01 0.04
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.09 1.05 1.07 1.06 1.06
Debt Service Coverage Ratio
80.38 0.00 -26.43 -45.60 -3.88
Interest Coverage Ratio
0.00 0.00 -27.81 -45.76 0.00
Debt to Market Cap
<0.01 0.00 <0.01 0.00 <0.01
Interest Debt Per Share
0.06 0.30 0.56 0.43 0.61
Net Debt to EBITDA
-2.29 -19.56 1.05 5.10 8.47
Profitability Margins
Gross Profit Margin
68.78%93.90%0.00%0.00%0.00%
EBIT Margin
33.32%25.44%0.00%0.00%0.00%
EBITDA Margin
45.67%35.31%0.00%0.00%0.00%
Operating Profit Margin
42.40%-216.43%0.00%0.00%0.00%
Pretax Profit Margin
50.10%25.44%0.00%0.00%0.00%
Net Profit Margin
53.30%21.56%0.00%0.00%0.00%
Continuous Operations Profit Margin
32.04%21.56%0.00%0.00%0.00%
Net Income Per EBT
106.40%84.76%100.00%100.00%100.00%
EBT Per EBIT
118.14%-11.75%96.40%101.90%97.48%
Return on Assets (ROA)
16.04%1.34%-25.06%-11.11%-10.35%
Return on Equity (ROE)
19.36%1.40%-26.80%-11.72%-11.01%
Return on Capital Employed (ROCE)
13.77%-13.97%-27.42%-11.37%-11.17%
Return on Invested Capital (ROIC)
11.26%-11.82%-33.88%-11.79%-11.12%
Return on Tangible Assets
16.04%1.34%-25.06%-11.11%-10.35%
Earnings Yield
3.17%0.32%-6.93%-4.48%-2.85%
Efficiency Ratios
Receivables Turnover
2.88 1.21 0.00 0.00 0.00
Payables Turnover
8.91 1.67 1.02 0.33 0.88
Inventory Turnover
0.50 0.44 0.00 0.00 0.00
Fixed Asset Turnover
2.39 0.30 0.00 0.00 0.00
Asset Turnover
0.30 0.06 0.00 0.00 0.00
Working Capital Turnover Ratio
0.47 0.11 0.00 0.00 0.00
Cash Conversion Cycle
820.95 908.56 -358.34 -1.11K -415.09
Days of Sales Outstanding
126.80 302.66 0.00 0.00 0.00
Days of Inventory Outstanding
735.12 824.02 0.00 0.00 0.00
Days of Payables Outstanding
40.96 218.13 358.34 1.11K 415.09
Operating Cycle
861.91 1.13K 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
6.09 -3.27 -3.95 -2.16 -1.39
Free Cash Flow Per Share
5.72 -3.70 -6.02 -5.24 -2.18
CapEx Per Share
0.37 0.43 2.08 3.08 0.79
Free Cash Flow to Operating Cash Flow
0.94 1.13 1.53 2.43 1.57
Dividend Paid and CapEx Coverage Ratio
16.60 -7.53 -1.90 -0.70 -1.76
Capital Expenditure Coverage Ratio
16.60 -7.53 -1.90 -0.70 -1.76
Operating Cash Flow Coverage Ratio
103.77 -10.97 -11.26 -5.97 -2.26
Operating Cash Flow to Sales Ratio
0.47 -1.75 0.00 0.00 0.00
Free Cash Flow Yield
2.63%-2.99%-7.60%-7.49%-3.63%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
31.58 308.15 -14.43 -22.32 -35.04
Price-to-Sales (P/S) Ratio
16.86 66.45 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
5.52 4.33 3.87 2.62 3.86
Price-to-Free Cash Flow (P/FCF) Ratio
38.00 -33.49 -13.15 -13.35 -27.54
Price-to-Operating Cash Flow Ratio
35.65 -37.93 -20.08 -32.39 -43.22
Price-to-Earnings Growth (PEG) Ratio
0.90 -2.87 -0.19 -0.27 -0.82
Price-to-Fair Value
5.52 4.33 3.87 2.62 3.86
Enterprise Value Multiple
34.62 168.59 -12.85 -18.67 -28.71
Enterprise Value
5.90B 3.02B 1.87B 1.22B 870.51M
EV to EBITDA
34.62 168.59 -12.85 -18.67 -28.71
EV to Sales
15.81 59.54 0.00 0.00 0.00
EV to Free Cash Flow
35.63 -30.00 -12.16 -10.49 -21.27
EV to Operating Cash Flow
33.49 -33.99 -18.56 -25.44 -33.37
Tangible Book Value Per Share
39.30 28.67 20.49 26.74 15.55
Shareholders’ Equity Per Share
39.30 28.67 20.49 26.74 15.55
Tax and Other Ratios
Effective Tax Rate
0.18 0.15 -0.24 -0.04 -0.05
Revenue Per Share
12.89 1.87 0.00 0.00 0.00
Net Income Per Share
6.87 0.40 -5.49 -3.13 -1.71
Tax Burden
1.06 0.85 1.00 1.00 1.00
Interest Burden
1.50 1.00 1.00 1.00 1.00
Research & Development to Revenue
0.15 0.92 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.14 0.79 0.00 0.00 0.00
Income Quality
0.89 -8.12 0.72 0.69 0.81
Currency in USD